Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurotrophin 3 | 9 | 2018 | 13 | 1.710 |
Why?
|
| Spinal Cord Injuries | 6 | 2014 | 273 | 1.110 |
Why?
|
| Nerve Regeneration | 8 | 2013 | 69 | 1.080 |
Why?
|
| Neuronal Plasticity | 6 | 2014 | 283 | 0.890 |
Why?
|
| Axons | 8 | 2013 | 386 | 0.730 |
Why?
|
| Genetic Vectors | 18 | 2015 | 892 | 0.670 |
Why?
|
| Growth Cones | 4 | 2013 | 15 | 0.620 |
Why?
|
| Nerve Growth Factors | 5 | 2007 | 65 | 0.570 |
Why?
|
| Rats | 21 | 2018 | 3370 | 0.570 |
Why?
|
| Adenoviridae | 11 | 2015 | 579 | 0.520 |
Why?
|
| Thymidine Kinase | 8 | 2002 | 90 | 0.470 |
Why?
|
| Central Nervous System | 4 | 2006 | 269 | 0.460 |
Why?
|
| Pyramidal Tracts | 5 | 2015 | 33 | 0.460 |
Why?
|
| Wallerian Degeneration | 1 | 2013 | 10 | 0.400 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 18 | 0.390 |
Why?
|
| Cerebral Cortex | 3 | 2006 | 445 | 0.390 |
Why?
|
| Gene Transfer Techniques | 4 | 2002 | 344 | 0.390 |
Why?
|
| Spinal Cord | 7 | 2015 | 255 | 0.380 |
Why?
|
| Motor Neurons | 4 | 2007 | 131 | 0.380 |
Why?
|
| Th2 Cells | 1 | 2013 | 188 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 5 | 1998 | 1075 | 0.350 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2013 | 1105 | 0.350 |
Why?
|
| Ganciclovir | 7 | 2002 | 101 | 0.340 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2006 | 89 | 0.320 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 65 | 0.300 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 60 | 0.300 |
Why?
|
| Transduction, Genetic | 6 | 2009 | 276 | 0.290 |
Why?
|
| Neurons | 4 | 2006 | 1979 | 0.280 |
Why?
|
| Simplexvirus | 6 | 2000 | 100 | 0.270 |
Why?
|
| Protein Kinases | 1 | 2009 | 312 | 0.270 |
Why?
|
| Immunohistochemistry | 8 | 2013 | 1591 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 480 | 0.250 |
Why?
|
| Genetic Therapy | 6 | 2008 | 713 | 0.250 |
Why?
|
| Animals | 32 | 2018 | 33912 | 0.250 |
Why?
|
| Raphe Nuclei | 1 | 2005 | 16 | 0.230 |
Why?
|
| Recovery of Function | 2 | 2018 | 449 | 0.220 |
Why?
|
| Bone Marrow Cells | 2 | 2003 | 243 | 0.210 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 5 | 2008 | 23 | 0.210 |
Why?
|
| Sciatic Nerve | 4 | 2003 | 57 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 587 | 0.200 |
Why?
|
| Avian Sarcoma Viruses | 4 | 2000 | 30 | 0.200 |
Why?
|
| Brain Neoplasms | 6 | 2007 | 1306 | 0.200 |
Why?
|
| Brain | 4 | 2013 | 3175 | 0.180 |
Why?
|
| Myelin Sheath | 3 | 1993 | 131 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2003 | 544 | 0.170 |
Why?
|
| Nerve Growth Factor | 3 | 2007 | 18 | 0.170 |
Why?
|
| Mice, Neurologic Mutants | 2 | 1992 | 74 | 0.170 |
Why?
|
| Myelin Basic Protein | 2 | 1992 | 67 | 0.170 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 4697 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 358 | 0.150 |
Why?
|
| Flow Cytometry | 3 | 2013 | 765 | 0.150 |
Why?
|
| Brain Diseases | 2 | 2005 | 299 | 0.150 |
Why?
|
| Cell Differentiation | 3 | 2007 | 1928 | 0.150 |
Why?
|
| Stroke | 2 | 2018 | 1061 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2002 | 235 | 0.140 |
Why?
|
| Defective Viruses | 1 | 1997 | 17 | 0.130 |
Why?
|
| Dextrans | 2 | 2007 | 42 | 0.130 |
Why?
|
| Biotin | 2 | 2007 | 39 | 0.130 |
Why?
|
| Locomotion | 2 | 2015 | 59 | 0.120 |
Why?
|
| Epithelium, Corneal | 2 | 2008 | 175 | 0.120 |
Why?
|
| Antimetabolites | 1 | 1996 | 27 | 0.120 |
Why?
|
| p-Chloroamphetamine | 2 | 2006 | 3 | 0.120 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 96 | 0.120 |
Why?
|
| Mastadenovirus | 1 | 1995 | 2 | 0.120 |
Why?
|
| Viral Proteins | 1 | 1997 | 337 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1995 | 66 | 0.110 |
Why?
|
| Chick Embryo | 2 | 2009 | 121 | 0.110 |
Why?
|
| Serotonin | 2 | 2006 | 208 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 235 | 0.110 |
Why?
|
| beta-Galactosidase | 4 | 2002 | 135 | 0.100 |
Why?
|
| Rats, Nude | 1 | 2013 | 10 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 43 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2013 | 68 | 0.100 |
Why?
|
| Cell Survival | 4 | 2008 | 826 | 0.100 |
Why?
|
| Peripheral Nerve Injuries | 1 | 1993 | 37 | 0.100 |
Why?
|
| Rats, Inbred F344 | 4 | 2002 | 99 | 0.100 |
Why?
|
| Schwann Cells | 1 | 1993 | 61 | 0.100 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 335 | 0.090 |
Why?
|
| Glioma | 2 | 1994 | 494 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2007 | 1246 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 526 | 0.080 |
Why?
|
| Limbus Corneae | 2 | 2007 | 31 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1205 | 0.080 |
Why?
|
| Female | 13 | 2018 | 70963 | 0.080 |
Why?
|
| Nerve Net | 1 | 2013 | 254 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2009 | 1013 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2007 | 2550 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 1992 | 2326 | 0.070 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2007 | 15 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2003 | 686 | 0.070 |
Why?
|
| Antiviral Agents | 4 | 2002 | 807 | 0.070 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 21 | 0.070 |
Why?
|
| Time Factors | 4 | 2018 | 6196 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 972 | 0.070 |
Why?
|
| Facial Nerve | 2 | 1998 | 25 | 0.070 |
Why?
|
| Facial Muscles | 2 | 1998 | 26 | 0.070 |
Why?
|
| Stem Cells | 3 | 2008 | 702 | 0.070 |
Why?
|
| Nerve Crush | 3 | 1998 | 8 | 0.070 |
Why?
|
| Receptor, trkA | 1 | 2007 | 18 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 429 | 0.060 |
Why?
|
| Injections, Intramuscular | 2 | 2018 | 185 | 0.060 |
Why?
|
| Serotonin Agents | 1 | 2006 | 14 | 0.060 |
Why?
|
| Microglia | 1 | 2007 | 147 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 299 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 928 | 0.060 |
Why?
|
| Signal Transduction | 1 | 1998 | 4686 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2007 | 410 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2005 | 44 | 0.060 |
Why?
|
| Gene Expression | 3 | 2007 | 1481 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 2323 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2005 | 270 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 962 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 663 | 0.050 |
Why?
|
| Medulloblastoma | 1 | 2007 | 377 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 142 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 1153 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 825 | 0.050 |
Why?
|
| Cornea | 1 | 2007 | 569 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 981 | 0.050 |
Why?
|
| Mice | 8 | 2013 | 18301 | 0.050 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 175 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2003 | 182 | 0.050 |
Why?
|
| Biological Transport | 1 | 2003 | 329 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 227 | 0.040 |
Why?
|
| Neurites | 1 | 2001 | 43 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2001 | 65 | 0.040 |
Why?
|
| Dependovirus | 1 | 2002 | 160 | 0.040 |
Why?
|
| Software | 1 | 2006 | 733 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 718 | 0.040 |
Why?
|
| Cell Communication | 1 | 2001 | 188 | 0.040 |
Why?
|
| Survival Rate | 2 | 1995 | 2114 | 0.040 |
Why?
|
| Memory | 1 | 2002 | 314 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2007 | 960 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2007 | 410 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 589 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2007 | 358 | 0.040 |
Why?
|
| Sensorimotor Cortex | 1 | 2018 | 4 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2904 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 448 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 808 | 0.040 |
Why?
|
| Algorithms | 1 | 2006 | 1680 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 975 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1722 | 0.030 |
Why?
|
| Radiography | 2 | 2000 | 743 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 409 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 70 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1997 | 39 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 81 | 0.030 |
Why?
|
| Pons | 1 | 1997 | 34 | 0.030 |
Why?
|
| Sigmodontinae | 1 | 1997 | 45 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 89 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2002 | 710 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 71 | 0.030 |
Why?
|
| Ciliary Neurotrophic Factor | 2 | 1993 | 9 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2003 | 4738 | 0.030 |
Why?
|
| Papio | 1 | 1996 | 58 | 0.030 |
Why?
|
| Virus Shedding | 1 | 1996 | 76 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1997 | 157 | 0.030 |
Why?
|
| Microinjections | 1 | 2015 | 38 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1996 | 226 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2003 | 12936 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 41 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 1207 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1996 | 394 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 1618 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1998 | 1021 | 0.030 |
Why?
|
| Forelimb | 1 | 2014 | 11 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 1447 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 1994 | 14 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 358 | 0.030 |
Why?
|
| Denervation | 1 | 2014 | 24 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 448 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3763 | 0.030 |
Why?
|
| Brain Stem | 1 | 2014 | 108 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 330 | 0.030 |
Why?
|
| Receptor, EphA4 | 1 | 2013 | 5 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 1280 | 0.020 |
Why?
|
| Ephrin-B3 | 1 | 2013 | 8 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1419 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 133 | 0.020 |
Why?
|
| Pia Mater | 1 | 1992 | 9 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1993 | 91 | 0.020 |
Why?
|
| Median Eminence | 1 | 1992 | 3 | 0.020 |
Why?
|
| Choroid Plexus | 1 | 1992 | 25 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2885 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 1992 | 73 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1992 | 80 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1992 | 92 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2015 | 385 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 133 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 263 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 305 | 0.020 |
Why?
|
| Humans | 9 | 2015 | 131163 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1992 | 110 | 0.020 |
Why?
|
| Reference Values | 1 | 1992 | 676 | 0.020 |
Why?
|
| Macrophages | 1 | 1994 | 667 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 1176 | 0.020 |
Why?
|
| Astrocytes | 1 | 1992 | 264 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2395 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2825 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1992 | 487 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 1990 | 96 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3464 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2008 | 44 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2007 | 5 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 8 | 0.020 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2007 | 107 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 201 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 194 | 0.020 |
Why?
|
| Male | 5 | 2014 | 64957 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 633 | 0.010 |
Why?
|
| Seizures | 1 | 1990 | 890 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 2595 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 680 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 52 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 39 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2002 | 16 | 0.010 |
Why?
|
| Methylnitrosourea | 1 | 2002 | 15 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 46 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2002 | 53 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 235 | 0.010 |
Why?
|
| Carcinogens | 1 | 2002 | 127 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2001 | 77 | 0.010 |
Why?
|
| Laminin | 1 | 2001 | 66 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 1339 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2001 | 230 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 108 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2001 | 270 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 303 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 273 | 0.010 |
Why?
|
| Gliosarcoma | 1 | 2000 | 7 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2465 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1590 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2001 | 316 | 0.010 |
Why?
|
| Prostate | 1 | 2001 | 404 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2002 | 587 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2000 | 101 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 3385 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 905 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 950 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2000 | 1216 | 0.010 |
Why?
|
| Aged | 2 | 2008 | 21025 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2000 | 371 | 0.010 |
Why?
|
| Middle Aged | 2 | 2008 | 28601 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 3360 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 10103 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 31282 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1994 | 700 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1992 | 21 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 181 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 234 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 420 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1992 | 688 | 0.000 |
Why?
|